{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699994232499200.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0091-6749(97)70106-4"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0091674997701064?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0091674997701064?httpAccept=text/plain"}},{"identifier":{"@type":"NAID","@value":"30016514527"}}],"dc:title":[{"@value":"Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380587982468882944","@type":"Researcher","foaf:name":[{"@value":"Quatyba A. Hamida"}]},{"@id":"https://cir.nii.ac.jp/crid/1380587982468882945","@type":"Researcher","foaf:name":[{"@value":"Elsa Schotmana"}]},{"@id":"https://cir.nii.ac.jp/crid/1380587982468882947","@type":"Researcher","foaf:name":[{"@value":"Mikila R. Jacobsonb"}]},{"@id":"https://cir.nii.ac.jp/crid/1380587982468882948","@type":"Researcher","foaf:name":[{"@value":"Samantha M. Walkerb"}]},{"@id":"https://cir.nii.ac.jp/crid/1380587982468882946","@type":"Researcher","foaf:name":[{"@value":"Stephen R. Durhamb"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00916749"}],"prism:publicationName":[{"@value":"Journal of Allergy and Clinical Immunology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1997-02","prism:volume":"99","prism:number":"2","prism:startingPage":"254","prism:endingPage":"260"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0091674997701064?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0091674997701064?httpAccept=text/plain"}],"createdAt":"2005-11-05","modifiedAt":"2025-09-25","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360848659542689536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204631311744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Allergen Immunotherapy and Tolerance"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204631516032","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Role of T cells in asthma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204631637376","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immunomodulation in the treatment and/or prevention of bronchial asthma."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204632046208","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current and potential improvements in the treatment of asthma from increased understanding of airway pathophysiology."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204632157696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Biomarkers for Allergen Immunotherapy in Cedar Pollinosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204980973568","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"アレルギー性鼻炎患者抗原特異的減感作療法と末梢単核球のサイトカイン産生について"},{"@language":"en","@value":"EFFECTS OF IMMUNOTHERAPY ON CYTOKINE PRODUCTION FROM PERIPHERAL BLOOD MONONUCLEAR CELLS IN PATIENT WITH HOUSE DUST MITE ALLERGIC RHINITIS"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679609332736","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Low-dose exogenous interleukin (IL)-12 enhances antigen-induced interferon-.GAMMA. production without affecting IL-10 production in asthmatics."},{"@value":"Low-Dose Exogenous Interleukin (IL)-12 Enhances Antigen-Induced Interferon-γ Production Without Affecting IL-10 Production in Asthmatics"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679609706624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Allergen Immunotherapy in Asthma: Current Status and Future Perspectives"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679610265728","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Allergen immunotherapy: Current and new therapeutic strategies."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679610627968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Amb a 1-immunostimulatory Oligodeoxynucleotide Conjugate Immunotherapy Increases CD4+CD25+ T Cells in the Nasal Mucosa of Subjects with Allergic Rhinitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679957629056","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"WHO見解書 : アレルゲン免疫療法:アレルギー疾患の治療ワクチン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390292472557973888","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Peptide immunotherapy for inhaled allergens"},{"@language":"ja","@value":"吸入抗原に対するペプチド免疫療法"}]},{"@id":"https://cir.nii.ac.jp/crid/1390301861421198720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Allergen immunotherapy in asthma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0091-6749(97)70106-4"},{"@type":"CIA","@value":"30016514527"},{"@type":"CROSSREF","@value":"10.2332/allergolint.o-07-528_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.3390/pathogens10111406_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.2332/allergolint.13-rai-0650_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.1046/j.1440-1592.2002.00258.x_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.2332/allergolint.46.73_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.1093/intimm/dxx034_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.2332/allergolint.09-rai-0150_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.1046/j.1440-1592.2002.00260.x_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.3388/jspaci.36.152_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.1046/j.1440-1592.2002.00272.x_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.1046/j.1440-1592.2001.00214.x_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"},{"@type":"CROSSREF","@value":"10.2332/allergolint.09-rai-0097_references_DOI_RpSXiN3ThF3dfwwXt1iYR3rec0J"}]}